Timothy Chan, M.D., Ph.D., chair of Cleveland Clinic‘s Global Center for Immunotherapy and Precision Immuno-Oncology and Sheikha Fatima Bint Mubarak Endowed Chair in Immunotherapy and Precision Immuno-Oncology, has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.
A renowned immuno-oncology and cancer genomics expert, Dr. Chan joined Cleveland Clinic in 2020 to found and lead the Global Center for Immunotherapy and Precision Immuno-Oncology, which brings together multidisciplinary experts from across the global health system to advance research and treatment related to the rapidly growing field of immuno-oncology.
Dr. Chan is a staff member in the Department of Radiation Oncology of the Cleveland Clinic Taussig Cancer Institute. He is also professor of medicine, co-director of the National Center for Regenerative Medicine of Case Western Reserve University and co-leader of the Immune Oncology Program, Case Comprehensive Cancer Center.
